China stands at the core of our legal and regulatory practice across the pharmaceutical, medical device, and cosmetics*industries.
Health Law Asia assists international and domestic clients in navigating China’s evolving healthcare framework, offering support in product registration, NMPA approvals, compliance strategies, licensing, distribution, and enforcement.
We also provide seamless legal services throughout Greater China — including Hong Kong, Macau, and Taiwan — as well as in key innovation zones such as the Greater Bay Area (GBA) and the Hainan Free Trade Port.
These regions feature unique regulatory pathways and accelerated access schemes. Our team offers tailored guidance on local procedures, cross-border operations, and integration within broader China market strategies.
With deep local insight and an international perspective, Health Law Asia helps clients succeed in both the core Chinese market and the wider regional healthcare ecosystem.
We offer specialized legal and regulatory advisory services to companies operating in Japan’s highly regulated healthcare market.
Our expertise covers compliance with the Pharmaceutical and Medical Device Act (PMD Act), product registration and approval procedures, advertising regulations, and distribution agreements.
Health Law Asia supports both international and domestic clients in navigating complex local frameworks, ensuring market access while mitigating legal and regulatory risks.
We also advise on corporate structuring, licensing, technology transfer, and strategic partnerships with Japanese entities.
South Korea’s healthcare market is a major hub in Asia, driven by innovation and regulatory evolution.
We assist pharmaceutical, medical device, and cosmetics companies with customized legal solutions designed to ensure regulatory compliance and commercial success.
Our services include end-to-end support for product approvals, clinical trial compliance, “advertising and promotion regulations”, and “market authorization” under Korean law.
We also advise on “distribution models”, “technology transfer”, “M&A”, and collaborations with local partners — aligning each legal strategy with the client’s operational and business objectives.
Vietnam’s rapidly expanding healthcare sector offers major opportunities but also significant regulatory complexity.
Health Law Asia helps clients navigate Vietnam’s evolving legal framework, ensuring compliance and smooth market entry for companies in the pharmaceutical, medical device, and cosmetics industries.
We support clients through all stages of market access, including product registration, import licensing, clinical trial requirements, and post-market surveillance.
Our legal team also assists in drafting and reviewing distribution and agency agreements, managing regulatory filings, and ensuring alignment with local healthcare laws.
Whether entering the Vietnamese market or expanding operations, we deliver strategic legal advice that connects regulatory compliance with business efficiency.
Thailand’s healthcare sector is developing rapidly and requires precise legal and regulatory planning for successful market entry.
We advise pharmaceutical, medical device, and cosmetics companies on how to meet Thailand’s complex healthcare requirements while maintaining operational efficiency.
Our services include assistance with FDA Thailand registrations, import permits, product labeling, clinical evaluations, and licensing procedures.
We also provide guidance on distribution partnerships, regulatory inspections, and market access strategy, helping clients ensure compliance and reduce risk across the Thai market.
Singapore is a strategic gateway to Asia’s healthcare sector — a hub known for its innovation, high standards, and strong regulatory oversight.
Health Law Asia provides legal and regulatory support to companies in the pharmaceutical, medical device, and cosmetics industries seeking to establish or expand operations in Singapore.
Our services include product registration with the Health Sciences Authority (HSA), compliance with the Health Products Act, labeling and advertising reviews, and clinical trial oversight.
We also assist with licensing strategies, distribution agreements, and regulatory due diligence.
With deep understanding of Singapore’s healthcare laws and business culture, our firm helps clients achieve sustainable success in one of Asia’s most advanced and competitive markets.